Opportunities and limits of cell-based assay miniaturization in drug discovery

Author： Carstens Cornelia Elbracht Rudi Gärtner Claudia Becker Holger

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.7, 2010-07, pp. : 673-679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell-based apoptosis assays in oncology drug discovery

By Drewe John Cai Sui Xiong

Expert Opinion on Drug Discovery, Vol. 5, Iss. 6, 2010-06 ,pp. : 583-596

Informa Healthcare

Access to resources Recommend Favorite

Viral-mediated gene delivery for cell-based assays in drug discovery

By Ames Robert S Lu Quinn

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 243-256

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targets in Cancer Drug Discovery: Cell-Based Profiling

Current Pharmaceutical Design, Vol. 6, Iss. 4, 2000-03 ,pp. : 473-483

Bentham Science Publishers

Access to resources Recommend Favorite

Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery

By Pinne Marija Raucy Judy L

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 669-686

Informa Healthcare

Access to resources Recommend Favorite

Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 629-639

Bentham Science Publishers

Access to resources Recommend Favorite